Crossmark

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Crossref DOI link: https://doi.org/10.1186/s12885-018-4644-7

Published Online: 2018-07-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lambert, Leah K.

Balneaves, Lynda G. http://orcid.org/0000-0002-6535-2096
Howard, A. Fuchsia

Chia, Stephen K.

Gotay, Carolyn C.
Funding

Funding for this research was provided by:

School of Nursing, University of British Columbia

Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2018-07-11
More Information

Article History

Received: 3 January 2018

Accepted: 28 June 2018

First Online: 11 July 2018

Ethics approval and consent to participate

: This study was approved by the University of British Columbia Behavioural Research Ethics Board certificate H13–00207. Written informed consent was obtained from all individual participants included in the study.

: Participants’ consent included the development of research reports (i.e. publications) on the condition of confidentiality in that no identifying information was included in the reports that would allow participants to be identified.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.